Contract facts
NONENo full NAICS 541714 intel page yet. Browse NAICS intelligence
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS. is a federal NONE award for National Institutes Of Health Niaid held by Versatope Therapeutics, Inc. Estimated value $22.6M ($9.7M obligated). Current period of performance ends Aug 31, 2027. Last award drew 12 bidders. Place of performance: LOWELL MA. Related solicitation HHSNIHNIAIDBAA2018.
TO ADVANCE THE LEAD UNIVERSAL INFLUENZA VACCINE CANDIDATE THROUGH A PHASE I CLINICAL STUDY AND TO EVALUATE THE LONG-TERM IMMUNOGENICITY WITH ONE AND / OR TWO IMMUNIZATIONS.
Recompete timing
PublicCurrent PoP ends Aug 31, 2027 (358 days remaining). Agencies typically plan 12–18 months ahead — at 11.8 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordVersatope Therapeutics, Inc — $7.7M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93019C00060?
75N93019C00060 (Advance the LEAD universal influenza vaccine) is a National Institutes Of Health Niaid award with a potential value of $22.6M, currently held by Versatope Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93019C00060?
National Institutes Of Health Niaid awarded 75N93019C00060 to Versatope Therapeutics, Inc (potential $22.6M).
Who is the incumbent on 75N93019C00060?
Versatope Therapeutics, Inc is the incumbent with $7.7M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Aug 31, 2027.
When does Versatope Therapeutics, Inc’s 75N93019C00060 come up for recompete?
SCOUT tracks a period-of-performance end of Aug 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Seen enough? Run one full capture cycle on 75N93019C00060 — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.